eZono AG, a healthcare products company based in Germany, successfully raised $10 million in an equity financing round. The company’s latest round of financing came from MVM Life Science Partners and will help the company expand its research and development initiatives.
According to a press release by the company, the latest financing round also includes a shakeup of eZono’s board of directors. Hugo Harrod, a partner at MVM Life Science, will join eZono’s board.
Allan Dunbar is the CEO of eZono. In prepared remarks, he said, "Having sold more than 450 eZono 3000 systems globally, we now take the next step with our novel needle guidance technology in 2013.” He continued, "Ultrasound guided regional anesthesia is a key driver for patient safety and reducing cost in surgery but adoption is still slow because of the difficulties inherent in guiding the needle to the nerve. Our needle guidance technology addresses this and should accelerate adoption."
eZono’s flagship product is a specialized portable ultrasound system that uses a tablet-style interface. The eZono 3000 includes a touch screen GUI and can help reduce the physician learning curve for regional anesthesia and other emergency care procedures. Unlike other products on the market, the eZono 3000 uses the company’s needle guidance technology, allowing the use of standardized needles for regional anesthesia with no increase in setup times. The eZono 3000 received clearance from the United States Food and Drug Administration in 2011.
- Selecting and Applying the Right Bag Sealer Technology - Supplier Resource
- Anaheim Learning Labs - Event
- MD&M West - Event
- Medical Design & Manufacturing Executive Summit - Event
- Developing & Validating a Molding Cell for Medical Products - Supplier Resource
- Additive Manufacturing 101: How the Future of Product Development and Manufacturing is Changing - Video